RS Therapy: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
RS Therapy
Largest movements
- Cash +€35,757
up €35,757 (+214.3%), from €16,682 to €52,439
mainly Net result for the year (+€28,492) and Depreciation (+€7,464)
- Tangible fixed assets -€7,464
down €7,464 (-20.9%), from €35,787 to €28,323
- Receivables within one year -€4,020
down €4,020 (-32.9%), from €12,223 to €8,203
- Profit (loss) carried forward +€27,662
up €27,662 (+104.9%), from €26,379 to €54,040
- Debts after one year -€8,136
down €8,136 (-34.0%), from €23,897 to €15,761
- Tax, wage and social debts +€3,246
up €3,246 (+171.2%), from €1,896 to €5,142
of which Taxes: +€2,510
- Accrued charges and deferred income +€1,000
new in 2024: €1,000
- Gross operating margin +€9,015
up €9,015 (+24.5%), from €36,858 to €45,873
- Depreciation +€5,930
up €5,930 (+386.7%), from €1,534 to €7,464
- Taxes +€804
up €804 (+10.5%), from €7,656 to €8,461
- Financial charges +€767
up €767 (+191.0%), from €401 to €1,168
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €65,715 | €89,966 | +€24,251 | +36.9% |
| Fixed assets | 21/28 | €35,787 | €28,323 | -€7,464 | -20.9% |
| Tangible fixed assets | 22/27 | €35,787 | €28,323 | -€7,464 | -20.9% |
| Furniture and vehicles | 24 | €35,787 | €28,323 | -€7,464 | -20.9% |
| Current assets | 29/58 | €29,928 | €61,643 | +€31,715 | +106.0% |
| Amounts receivable within one year | 40/41 | €12,223 | €8,203 | -€4,020 | -32.9% |
| Trade receivables | 40 | €12,223 | €8,203 | -€4,020 | -32.9% |
| Cash at bank and in hand | 54/58 | €16,682 | €52,439 | +€35,757 | +214.3% |
| Deferred charges and accrued income | 490/1 | €1,023 | €1,001 | -€22 | -2.2% |
| Total equity and liabilities | 10/49 | €65,715 | €89,966 | +€24,251 | +36.9% |
| Equity | 10/15 | €28,379 | €56,040 | +€27,662 | +97.5% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €26,379 | €54,040 | +€27,662 | +104.9% |
| Amounts payable | 17/49 | €37,336 | €33,926 | -€3,410 | -9.1% |
| Amounts payable after more than one year | 17 | €23,897 | €15,761 | -€8,136 | -34.0% |
| Financial debts | 170/4 | €23,897 | €15,761 | -€8,136 | -34.0% |
| Amounts payable within one year | 42/48 | €13,439 | €17,165 | +€3,726 | +27.7% |
| Current portion of amounts payable after more than one year | 42 | €7,827 | €8,136 | +€309 | +3.9% |
| Trade debts | 44 | €347 | €679 | +€332 | +95.5% |
| Suppliers | 440/4 | €347 | €679 | +€332 | +95.5% |
| Taxes, remuneration and social security | 45 | €1,896 | €5,142 | +€3,246 | +171.2% |
| Taxes | 450/3 | €1,896 | €4,406 | +€2,510 | +132.3% |
| Remuneration and social security | 454/9 | - | €736 | +€736 | |
| Other amounts payable | 47/48 | €3,368 | €3,207 | -€161 | -4.8% |
| Accrued charges and deferred income | 492/3 | - | €1,000 | +€1,000 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,534 | €7,464 | +€5,930 | +386.7% |
| Other operating charges | 640/8 | €88 | €289 | +€201 | +229.2% |
| Gross operating margin | 9900 | €36,858 | €45,873 | +€9,015 | +24.5% |
| Operating profit (loss) | 9901 | €35,237 | €38,120 | +€2,884 | +8.2% |
| Financial income | 75/76B | - | €0 | +€0 | |
| Recurring financial income | 75 | - | €0 | +€0 | |
| Financial charges | 65/66B | €401 | €1,168 | +€767 | +191.0% |
| Recurring financial charges | 65 | €401 | €1,168 | +€767 | +191.0% |
| Profit (loss) for the period before taxes | 9903 | €34,835 | €36,952 | +€2,117 | +6.1% |
| Income taxes | 67/77 | €7,656 | €8,461 | +€804 | +10.5% |
| Profit (loss) for the period | 9904 | €27,179 | €28,492 | +€1,313 | +4.8% |
| Profit (loss) for the period to be appropriated | 9905 | €27,179 | €28,492 | +€1,313 | +4.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.